Pharmaceutical

CO2Meter Launches GasLab® Industrial Fixed Gas Detector Series

CO2Meter launches new Industrial Gas Detector Series featuring up to 128 sensor capabilities ORMOND BEACH, Fla., June 18, 2024 /PRNewswire/…

1 month ago

Axtria Announces its First Ignite Leadership Award Honorees

Award Honors Top Executives Fueling Innovation and Impact in the Life Sciences Industry BERKELEY HEIGHTS, N.J., June 18, 2024 /PRNewswire/ --…

1 month ago

Petauri Adds Mtech Access and Delta Hat in Global Expansion

Rapidly growing pharmaceutical services platform announces transformational expansion, acquiring two leading businesses focused on evidence-based value demonstration and global market…

1 month ago

Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent

CHICAGO, IL / ACCESSWIRE / June 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 month ago

Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be…

1 month ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debtInterest…

1 month ago

Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically

TORONTO, ON / ACCESSWIRE / June 18, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

1 month ago

Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers

Day One receives exclusive license for development and commercialization of MTX-13 (DAY301), which received IND clearance by the FDA in…

1 month ago

Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET

NOTE CHANGE IN DATE OF UPDATE CALL TO THURSDAY JUNE 20thCANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences,…

1 month ago

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference

SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…

1 month ago